Observational Study to Evaluate the Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis
Phase of Trial: Phase I
Latest Information Update: 08 Feb 2018
At a glance
- Drugs Autologous stem cell therapy (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors EHL Bio
- 05 Feb 2018 Status changed from active, no longer recruiting to recruiting.
- 30 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 22 Sep 2017 Planned End Date changed from 1 Sep 2022 to 19 Sep 2022.